| Literature DB >> 35681456 |
Ivan Mestres1, Judith Houtman2, Federico Calegari1, Tomohisa Toda2.
Abstract
Successful embryonic and adult neurogenesis require proliferating neural stem and progenitor cells that are intrinsically and extrinsically guided into a neuronal fate. In turn, migration of new-born neurons underlies the complex cytoarchitecture of the brain. Proliferation and migration are therefore essential for brain development, homeostasis and function in adulthood. Among several tightly regulated processes involved in brain formation and function, recent evidence points to the nuclear envelope (NE) and NE-associated components as critical new contributors. Classically, the NE was thought to merely represent a barrier mediating selective exchange between the cytoplasm and nucleoplasm. However, research over the past two decades has highlighted more sophisticated and diverse roles for NE components in progenitor fate choice and migration of their progeny by tuning gene expression via interactions with chromatin, transcription factors and epigenetic factors. Defects in NE components lead to neurodevelopmental impairments, whereas age-related changes in NE components are proposed to influence neurodegenerative diseases. Thus, understanding the roles of NE components in brain development, maintenance and aging is likely to reveal new pathophysiological mechanisms for intervention. Here, we review recent findings for the previously underrepresented contribution of the NE in neuronal commitment and migration, and envision future avenues for investigation.Entities:
Keywords: aging; chromatin regulation; development; neurogenesis; neuronal migration; nuclear envelope
Mesh:
Year: 2022 PMID: 35681456 PMCID: PMC9179901 DOI: 10.3390/cells11111761
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
Figure 1Scheme of the embryonic cortex illustrating essential steps during neurogenesis that are known to be regulated by NE proteins. NSCs make contact with both apical and basal lamina, and their soma undergoes interkinetic nuclear migration (INM) following the cell cycle. Mitoses occur at the ventricular surface of the cortex, beginning with nuclear envelope breakdown (NEBD). Mitotic spindle orientation (∡) determines whether a cell division will be symmetric (producing two identical daughter cells) or asymmetric (producing one NSC and another daughter with a more restricted cell fate). Once mitosis is complete, new-born neurons migrate to their final position within the cortical plate. Intermediate basal progenitors were omitted for simplicity. Mutations in NE components often lead to nuclear rupture or deformation in migrating neurons, causing blebs and elongations.
Figure 2Scheme of the nuclear envelope and the associated components discussed in the main text. NPC, nuclear pore complex; TF, transcription factor; me, methylation; ac, acetylation.
Nuclear envelope components known to affect neural development.
| NE Component | Species | Cell Type | Phenotype | Reference |
|---|---|---|---|---|
|
| Drosophila melanogaster | Photoreceptor | Rough eyes | [ |
|
| Drosophila melanogaster | Neuroblast | Extended neurogenesis | [ |
|
| Mus musculus | Radial glial cells and neurons | Disorganized cortex, smaller cerebellum | [ |
|
| Nocturnal mammals | Rods | Heterochromatin inversion | [ |
|
| Mus musculus | Olfactory neurons | Co-expression of multiple olfactory genes, and glomeruli mistargeting | [ |
|
| Mus musculus | Radial glial cells | Lissencephalic brain | [ |
|
| Danio rerio | Retinal ganglion cells | Smaller eyes | [ |
|
| Mus musculus, Rattus norvegicus | Radial glial cells and neurons | Exencephalic neural tube | [ |
|
| Mus musculus | Radial glial cells and neurons | Inverted cortex and enlarged ventricles | [ |
Changes in NE components (bold letter) upon aging and in neurodegenerative diseases and the resulting phenotypes. iN, neurons directly reprogrammed from human-derived fibroblasts; mHtt, mutant Huntingtin; HD, Huntington’s disease; ALS, amyotrophic lateral sclerosis; FTD, frontotemporal dementia; pTau, hyperphosphorylated tau; AD, Alzheimer’s disease; CA1, cornu ammunis 1; PKC, protein kinase C; polyQ, poly-glutamine; DRPLA, dentatorubral-pallidoluysian atrophy; ADLD, adult-onset autosomal dominant leukodystropy; LRRK2, leucine-rich repeat kinase 2; PD, Parkinson’s disease.
| NE Component | Species | Cell Type | Change from Physiological State | NE Component Changes | Phenotype | Refs. |
|---|---|---|---|---|---|---|
|
| Homo sapiens | iN | Aging | Age-dependent transcription level decrease | Decline in nucleocytoplasmic compartmentalization, age-associated transcriptome | [ |
|
| Mus musculus | Cortical neurons | mHtt (HD) | Interaction with mHtt, subsequent accumulation and perinuclear mislocalization | Disrupted nucleocytoplasmic transport, leaky and compromised nuclear pore | [ |
|
| Homo sapiens | Neurons from patient-derived iPSC | C9orf72 mutation (ALS/FTD) | Accumulation and perinuclear mislocalization | Nucleocytoplasmic transport defects | [ |
|
| Homo sapiens | Hippocampal neurons | pTau (AD) | Interacts with pTau, accumulation and perinuclear mislocalization | Hampers nucleocytoplasmic transport, disrupts NPC distribution, accelerates and stabilizes pTau aggregation | [ |
|
| Drosophila melanogaster | Cortical neurons | pTau (AD) | Interaction with pTau subsequent induction filamentous actin, mislocalization in foci and nuclear blebs | Lamin B loss, nuclear invaginations, heterochromatin relaxation and DNA damage | [ |
|
| Homo sapiens | Frontal cortex neurons | pTau (AD) | Reduction in protein level | Nuclear invagination, heterochromatin relaxation | [ |
|
| Homo sapiens | Neuroblastoma cells | Aβ42 (AD) | Protein cleavage after Aβ42 dependent release of Cathepsin L from lysosomes | Nuclear invaginations | [ |
|
| Mus musculus | Hippocampal CA1 & striatal neurons | Downregulated PKCδ kinase (HD) | Protein level increase up to 4× wildtype level | Altered nuclear morphology, transcriptional changes | [ |
|
| Homo sapiens | Neurons/patient-derived fibroblasts | PolyQ ataxin (DRPLA) | Protein level decrease and co-localization with ataxin aggregates | Cytoplasmic localization and degradation, nuclear invagination | [ |
|
| Homo sapiens | HEK293 | ADLD | Extra copy of | Altered nuclear morphology | [ |
|
| Homo sapiens | Patient-derived fibroblasts | ADLD | Extra copy of | Enhanced nuclear stiffness, reduced ion channel opening capacity, reduced proliferation | [ |
|
| Homo sapiens | Neurons from patient-derived iPSC, brain sections | Abolished interaction between LRRK2 and lamins | Decline in nucleocytoplasmic compartmentalization, nuclear envelope disorganization | [ |
List of human disorders and conditions associated with mutations in NE components (bold letter). Note that some NE proteins have additional sub-cellular localizations, and whether the reported disorder is due to the role of the gene product in the NE or elsewhere remains to be clarified. ADHD, attention deficit hyperactivity disorder; ANE1, acute necrotizing encephalopathy type 1; ASD, autism spectrum disorder; B, bipolar disorder; CA, cerebellar ataxia; D, depression; EPI, epilepsy; IBSN, infantile bilateral striatal necrosis; ID, intellectual disability; SCZ, schizophrenia.
| Gene | Disorder/Condition | Localization in Addition to the NE | References |
|---|---|---|---|
|
| Triple-A syndrome | [ | |
|
| ASD | mitochondria, cytoplasm | [ |
|
| SCZ, ASD | cytoplasm | [ |
|
| ASD, ID, EPI | vesicles, cytoplasm | [ |
|
| IBSN | [ | |
|
| Microcephaly | [ | |
|
| Microcephaly | [ | |
|
| ASD, Microcephaly | [ | |
|
| ASD | [ | |
|
| Microcephaly | [ | |
|
| ANE1 | [ | |
|
| ASD | ER, cytoplasm | [ |
|
| ASD, CA, B, D | nucleus, cytoplasm | [ |
|
| ASD, ID | nucleus, cytoplasm | [ |
|
| ASD | [ | |
|
| ASD, ADHD | vesicles, cytoplasm | [ |
|
| ASD | nucleoplasm, cytoplasm | [ |